SCHEMBL18756686

SCHEMBL18756686

CC(=O)c1cc(Cc2ccc(C#N)cc2)c(Cl)c(C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 1/20 0.40
▸ SAE1 Q9UBE0 1/20 0.40
▸ UBA2 Q9UBT2 1/20 0.40
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ P2RY14 Q15391 1/20 0.38
▸ CYP19A1 P11511 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ DCTPP1 Q9H773 1/20 0.36
▸ LOXL2 Q9Y4K0 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ GRM2 Q14416 1/20 0.36
▸ AR P10275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18756053 0.85 RAB9A (0.38) P2RY14
SCHEMBL18756583 0.78 ALDH1A1 (0.46) SMN1; SMN2ALDH1A1MAPT
SCHEMBL18756685 0.77 CHRM1 (0.51) —
SCHEMBL18725364 0.77 CHRM1 (0.51) —
SCHEMBL18756168 0.75 CHRM1 (0.45) CYP19A1
SCHEMBL18725487 0.74 CHRM1 (0.50) —
SCHEMBL18756126 0.74 GRM2 (0.42) SMN1; SMN2MAPTGRM2
SCHEMBL21235170 0.71 KDM4E (0.30) SMN1; SMN2
SCHEMBL22232495 0.70 IDH1 (0.45) IDH1SAE1UBA2CYP11B1CYP11B2
SCHEMBL18756092 0.69 CYP11B1 (0.41) CYP11B1CYP11B2ALDH1A1MAPTGRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3156397-B1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2019-08-07 — — EP disclosed
EP-3156397-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2017-04-19 — — EP disclosed
Send feedback